|
Real-time
Oslo Bors
08:15:00 09/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.7000 NOK | +40.56% |
|
-.--% | -49.28% |
| 03/09 | EXACT Therapeutics AS Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 30/06 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| Market Cap | 4.43Cr 46.38L 41.8L 38.62L 34.92L 66.06L 44Cr 67.69L 4.63Cr 1.84Cr 23Cr 1.74Cr 1.7Cr 74Cr | P/E 2024 |
-2.49x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.04Cr 21.34L 19.23L 17.77L 16.06L 30.39L 20Cr 31.14L 2.13Cr 84.87L 11Cr 80.08L 78.38L 34Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,07,44,37,000x |
| Free-Float |
28.08% | Yield 2024 * |
-
| Yield 2025 | - |
Oslo BorsNOK
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| EXTX | Real-time | |
Deutsche Boerse AG
| 56F | Delayed |
| 1 day | +40.56% | ||
| 6 months | -45.74% | ||
| Current year | -49.28% |
| Current year | 0.43 |  | 2.7 |
| 1 year | 0.43 | | 2.7 |
| 3 years | 0.43 | | 12.5 |
| 5 years | 0.43 | | 21 |
| 10 years | 0.43 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Per Walday
CEO | Chief Executive Officer | 66 | 06/06/2022 |
Svein Kvåle
COO | Chief Operating Officer | - | 01/01/2012 |
John Edminson
DFI | Director of Finance/CFO | - | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 22/06/2018 | |
Anders Wold
CHM | Chairman | - | 08/06/2022 |
| Director/Board Member | 59 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/01/23 | Buy | Chairman | 2,500 | 0.0083% | ||
| 04/01/23 | Buy | Founder | 2,500 | 0.0083% | ||
| 04/01/23 | Buy | Chief Financial Officer | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +40.56% | -.--% | -51.05% | -94.35% | 47.04L | |
| -1.06% | -0.07% | +60.76% | +68.61% | 6.75TCr | |
| +1.01% | +8.39% | +13.62% | +92.13% | 6.07TCr | |
| +0.15% | -1.04% | +19.98% | +98.27% | 5.57TCr | |
| -0.95% | +11.17% | +22.21% | +110.93% | 4.8TCr | |
| -0.23% | +4.07% | +25.63% | +40.08% | 4.52TCr | |
| -6.40% | -9.51% | +181.99% | +816.79% | 3.91TCr | |
| +1.97% | +3.50% | +25.78% | +50.98% | 3.53TCr | |
| -1.81% | -3.22% | +78.99% | +55.80% | 3.35TCr | |
| +1.05% | +9.77% | -37.66% | +408.42% | 2.65TCr | |
| Average | +4.14% | +1.90% | +34.03% | +164.77% | 4TCr | |
| Weighted average by Cap. | +0.02% | +1.64% | +43.58% | +168.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0.01 0 0.01 0.58 0.01 0.06 0.02 0.31 0.02 0.02 0.99 |
| Net income | -5.23Cr -54.81L -49.4L -45.64L -41.26L -78.06L -51Cr -79.99L -5.47Cr -2.18Cr -28Cr -2.06Cr -2.01Cr -88Cr | -8.7Cr -91.09L -82.1L -75.85L -68.57L -1.3Cr -85Cr -1.33Cr -9.09Cr -3.62Cr -46Cr -3.42Cr -3.35Cr -145.61Cr |
| Net Debt | -9.89Cr -1.04Cr -93.35L -86.25L -77.97L -1.48Cr -97Cr -1.51Cr -10Cr -4.12Cr -52Cr -3.89Cr -3.8Cr -165.57Cr | -2.39Cr -25.04L -22.57L -20.85L -18.85L -35.67L -23Cr -36.55L -2.5Cr -99.62L -13Cr -93.99L -91.99L -40Cr |
Employees
11
- Stock Market
- Stocks
- EXTX Stock
Select your edition
All financial news and data tailored to specific country editions
